Invention Grant
- Patent Title: Positron emitting radionuclide labeled peptides for human uPAR PET imaging
-
Application No.: US14649113Application Date: 2013-11-29
-
Publication No.: US09884131B2Publication Date: 2018-02-06
- Inventor: Andreas Kjaer , Morten Persson , Jacob Madsen
- Applicant: Curasight ApS
- Applicant Address: DK Copenhagen N
- Assignee: CURASIGHT APS
- Current Assignee: CURASIGHT APS
- Current Assignee Address: DK Copenhagen N
- Agency: Merchant & Gould P.C.
- Priority: DK201270751 20121203
- International Application: PCT/DK2013/050402 WO 20131129
- International Announcement: WO2014/086364 WO 20140612
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61M36/14 ; A61K51/08 ; A61K38/08
Abstract:
There is provided a positron-emitting radionuclide labelled peptide for non-invasive PET imaging of the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. More specifically the invention relates to human uPAR PET imaging of any solid cancer disease for diagnosis, staging, treatment monitoring and especially as an imaging biomarker for predicting prognosis, progression and recurrence.
Public/Granted literature
- US20160263260A1 POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING Public/Granted day:2016-09-15
Information query
